ROCKVILLE, Md—The FDA has approved two new indications for Zeneca’s tamoxifen(Drug information on tamoxifen) (Nolvadex): For reducing the incidence of breast cancer in high-risk women, and for the reduction of contralateral breast cancer. In addition, data from clinical trials that support 5 years of adjuvant Nolvadex for breast cancer patients were added to the Nolvadex label.
|
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners Courtney H. Lyder, ND, May 17, 2013 With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy. VWhat Physicians Can Learn from the Allscripts EHR Lawsuit Marisa Torrieri, May 16, 2013 Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse? Eight Ways ICD-9 Will Still Matter to Medical Practices Brenda Edwards, CPC, May 15, 2013 What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it. Seven Ways Technology Can Speed Up Patient Collections Cheyenne Brinson, May 15, 2013 Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right. Four Reasons Private Medical Practice is Becoming Extinct Carol Stryker, May 15, 2013 It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
MOST POPULAR
CancerNetwork on Facebook
|
|
CancerNetwork |
ConsultantLive |
Diagnostic Imaging |
Musculoskeletal Network |
OBGYN.net |
PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources
© 1996 - 2013 UBM Medica LLC, a
UBM company
Privacy Statement -
Terms of Service -
Advertising Information -
Editorial Policy Statement -
UBM Medica Network Privacy Policy